Weiner LM - Search Results

1

Vaccine prevention of cancer: can endogenous antigens be targeted?

Weiner LM, Surana R, Murray J. Weiner LM, et al. Cancer Prev Res (Phila). 2010 Apr;3(4):410-5. doi: 10.1158/1940-6207.CAPR-10-0040. Epub 2010 Mar 23. Cancer Prev Res (Phila). 2010. PMID: 20332297 Free PMC article. Review.

2

Cancer immunotherapy--the endgame begins.

Weiner LM. Weiner LM. N Engl J Med. 2008 Jun 19;358(25):2664-5. doi: 10.1056/NEJMp0803663. N Engl J Med. 2008. PMID: 18565858 Free PMC article. No abstract available.

3

Monoclonal antibodies for cancer immunotherapy.

Weiner LM, Dhodapkar MV, Ferrone S. Weiner LM, et al. Lancet. 2009 Mar 21;373(9668):1033-40. doi: 10.1016/S0140-6736(09)60251-8. Lancet. 2009. PMID: 19304016 Free PMC article. Review.

4

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.

Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM. Cheever MA, et al. Among authors: weiner lm. Clin Cancer Res. 2009 Sep 1;15(17):5323-37. doi: 10.1158/1078-0432.CCR-09-0737. Clin Cancer Res. 2009. PMID: 19723653 Free PMC article.

5

Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Weiner LM, Surana R, Wang S. Weiner LM, et al. Nat Rev Immunol. 2010 May;10(5):317-27. doi: 10.1038/nri2744. Nat Rev Immunol. 2010. PMID: 20414205 Free PMC article. Review.

6

Monoclonal antibodies for the treatment of cancer.

Shuptrine CW, Surana R, Weiner LM. Shuptrine CW, et al. Among authors: weiner lm. Semin Cancer Biol. 2012 Feb;22(1):3-13. doi: 10.1016/j.semcancer.2011.12.009. Epub 2012 Jan 8. Semin Cancer Biol. 2012. PMID: 22245472 Free PMC article. Review.

7

Antibody-based immunotherapy of cancer.

Weiner LM, Murray JC, Shuptrine CW. Weiner LM, et al. Cell. 2012 Mar 16;148(6):1081-4. doi: 10.1016/j.cell.2012.02.034. Cell. 2012. PMID: 22424219 Free PMC article. Review.

8

Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy.

Kim B, Wang S, Lee JM, Jeong Y, Ahn T, Son DS, Park HW, Yoo HS, Song YJ, Lee E, Oh YM, Lee SB, Choi J, Murray JC, Zhou Y, Song PH, Kim KA, Weiner LM. Kim B, et al. Among authors: weiner lm. Oncogene. 2015 Feb 26;34(9):1083-93. doi: 10.1038/onc.2014.51. Epub 2014 Mar 24. Oncogene. 2015. PMID: 24662823 Free PMC article.

9

IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model.

Surana R, Wang S, Xu W, Jablonski SA, Weiner LM. Surana R, et al. Among authors: weiner lm. Cancer Immunol Res. 2014 Nov;2(11):1103-12. doi: 10.1158/2326-6066.CIR-14-0103. Epub 2014 Sep 9. Cancer Immunol Res. 2014. PMID: 25204776 Free PMC article.

10

The development of immunoconjugates for targeted cancer therapy.

Smaglo BG, Aldeghaither D, Weiner LM. Smaglo BG, et al. Among authors: weiner lm. Nat Rev Clin Oncol. 2014 Nov;11(11):637-48. doi: 10.1038/nrclinonc.2014.159. Epub 2014 Sep 30. Nat Rev Clin Oncol. 2014. PMID: 25265912 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

302 results

Search Page